You are here

skin infections

FDA Greenlights AbbVie’s Antibiotic Dalvance for Acute Skin Infections in Children

BioSpace

Sat, 07/24/21 - 06:36 pm

skin infections

Ligand acquires milestone and royalty rights to SB206 from Novan

Pharmaceutical Business Review

Tue, 05/7/19 - 10:05 am

Ligand Pharmaceuticals

skin infections

Motif delivers more strong data on its antibiotic

Biopharma Dive

Thu, 10/5/17 - 06:07 pm

Motif Biosciences

skin infections

Paratek Makes Milestone Movement in Late-Stage Trial

24/7 Wall St

Fri, 06/17/16 - 12:12 pm

clinical trials

skin infections

Durata Therapeutics presents new efficacy review of dalbavancin

The Fly on the Wall

Wed, 10/2/13 - 09:33 am

Durata Therapeutics

skin infections